CARE Ratings Ltd (CARERATING) — shareholding pattern, promoter holding, financials and share price

About CARE Ratings Ltd (CARERATING)

CARE Ratings Ltd operates in the Ratings industry, within the Financial Services sector. It trades on the NSE as CARERATING and on the BSE under scrip code 534804. Its ISIN is INE752H01013.

CARE Ratings is a leading credit rating agency of India. The Company provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own riskreturn expectations.(Source : 202003-01 Annual Report Page No:134)

CareEdge (CARE Ratings Limited) is an India‑based knowledge and analytics group that provides credit ratings, analytics, consulting and sustainability services; it is India’s second‑largest credit rating agency with a group of subsidiaries covering analytics, ESG ratings and global IFSC operations, serving corporates, financial institutions and international sovereign and debt issuers.

Financial momentum is visible in Q3 and 9M FY26: consolidated revenue rose 16% in Q3 and 17% in 9M to Rs. 112.12 Cr and Rs. 342.40 Cr respectively, while consolidated PAT margin expanded to 32% for 9M FY26, reflecting disciplined cost management and broad‑based growth across ratings and non‑ratings businesses.

Listed peers in Ratings: NDR INVIT Trust, Shrem InvIT, ICRA Ltd, Canara Robeco Asset Management Company Ltd, Share India Securities Ltd, Anand Rathi Share & Stock Brokers Ltd.

Valuation & Returns

10 Jul 2026

At ₹1,653.05 a share on 10 Jul 2026, CARE Ratings Ltd (CARERATING) was valued at a price-to-earnings ratio of 28.61x against an industry P/E of 43.11x and a price-to-book of 5.33x on a book value of ₹310.19 per share as of Mar 2026. Solomo computes return on equity of 18.63% and return on capital employed of 24.81% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
28.61x
Industry P/E
43.11x
P/B
5.33x
EPS (TTM)
₹57.78
Book value / share
₹310.19
ROE
18.63%
ROCE
24.81%
ROA
15.72%
Debt / equity
0.03x
Dividend yield
1.33%
EBITDA margin
53.31%
52-week range
₹1,393.95 – ₹1,885.1

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, CARE Ratings Ltd (CARERATING) reported revenue of ₹473 crore, net profit of ₹174 crore and earnings per share of ₹56.97. That compares with revenue of ₹402 crore and net profit of ₹140 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹131 crore and net profit ₹53 crore (consolidated).

Consolidated annual results for CARE Ratings Ltd (CARERATING), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)248279332402473
Net profit (₹ cr)7785103140174
EPS (₹)25.3428.1233.6745.8556.97
Compound annual growth for CARE Ratings Ltd (CARERATING). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth3.66%12.03%15.93%17.59%
Profit growth1.52%15.23%18.88%24.07%
Stock price CAGR6%19%32%-7%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 0% of CARE Ratings Ltd (CARERATING) (unchanged from the previous quarter), foreign institutional investors (FII) hold 23.41% and domestic institutional investors (DII) hold 31.58%. Market capitalisation was ₹4,969 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2012.

Largest disclosed public shareholders in Jun 2026: CRISIL LIMITED 8.72%, LIFE INSURANCE CORPORATION OF INDIA 8.5%, NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MUL 7.45%, PARI WASHINGTON INDIA MASTER FUND, LTD. 5.19%, ISIF EQUITY EX-TOP 100 LONG-SHORT FUND 3.29%, WHITEOAK CAPITAL FLEXI CAP FUND 3.13%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 20260%-23.41%31.58%100%
Mar 20260%-23.25%31.39%100%
Dec 20250%-23%31.3%100%
Sep 20250%-23.61%31.6%100%
Jun 20250%-24.62%29.76%100%
Mar 20250%-23.74%29.38%100%
Dec 20240%-24.75%27.51%100%
Sep 20240%-24.8%25.28%100%
Every quarter since Dec 2012 Filing data, not investment advice.